Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock
12:51pm, Monday, 29'th Dec 2025
Cathie Wood's Ark Invest increased stakes in gene-editing and autonomous mobility companies while trimming holdings in Tesla (TSLA) and Rocket Lab (RKLB).Sellin
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
12:00am, Saturday, 20'th Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
08:00am, Thursday, 18'th Dec 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
01:15pm, Friday, 12'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciar
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
08:00am, Thursday, 04'th Dec 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to suppo
Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
09:19am, Wednesday, 03'rd Dec 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST)
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
12:00am, Monday, 01'st Dec 2025
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength
04:32pm, Tuesday, 18'th Nov 2025
Twist's revenue growth continues to moderate due to macro headwinds and temporary challenges in the NGS business. The Biopharma segment is reaccelerating, though, driven by AI-enabled drug discovery c
Can Twist Bioscience Drop More?
09:25am, Monday, 17'th Nov 2025
Twist Bioscience (TWST) stock has decreased by 10.1% in one day. The recent downturn signifies renewed worries regarding wider-than-anticipated losses and ambiguous profitability guidance, but signifi
Twist Bioscience (NASDAQ:TWST) Hits New 12-Month Low Following Weak Earnings
02:19am, Saturday, 15'th Nov 2025
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report)'s share price reached a new 52-week low during trading on Friday following a weaker than expected earnings announcement. The company trade
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript
12:01pm, Friday, 14'th Nov 2025
Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
11:29am, Friday, 14'th Nov 2025
Twist Bioscience Corporation (NASDAQ: TWST) on Friday posted mixed fourth-quarter results, reporting a loss of 45 cents per share, slightly wider than the consensus estimate of a 43-cent loss.
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
09:25am, Friday, 14'th Nov 2025
Twist Bioscience (TWST) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.59 per share a year ago.
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
07:15am, Friday, 14'th Nov 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the
